All In Biotech

Drug Trial Radar · NCT05327114

Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Phase 2/3, Multistage, Multicenter, Randomized, Double-Blind, Placebo-Controlled Parallel Group Withdrawal Study to Evaluate the Efficacy and Safety of Nipocalimab Administered to Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Last checked: Nov 20, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 201 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

201

Planned (sponsor's estimate)

Start

Sep 23, 2022

Primary completion

Dec 15, 2026

Study completion Jul 11, 2028

Sponsor

Lead sponsor
Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
Sponsor type
Industry
First posted
Apr 14, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of this study is to evaluate the safety and efficacy of nipocalimab compared to placebo in delaying relapse in adults with chronic inflammatory demyelinating polyneuropathy (CIDP) who initially respond to nipocalimab in Stage A.

Conditions

  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

Interventions

  • NipocalimabDrug

    Nipocalimab will be administered intravenously.

  • PlaceboDrug

    Placebo will be administered intravenously.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Stage B: Time to First Occurrence of a Relapse EventTime frame: Up to 52 weeks

Locations

120 sites in 19 countries. Site status is shown where the registry gives one.

  • IMMUNOe Health and Research Centers

    Centennial, Colorado · Active not recruiting

  • Healthcare Innovations Institute Inc

    Coral Springs, Florida · Completed

  • Neurology Associates PA

    Maitland, Florida · Completed

  • ALS Center at the University of Miami

    Miami, Florida · Active not recruiting

  • Augusta University

    Augusta, Georgia · Completed

  • University of Kansas Medical Center

    Kansas City, Kansas · Completed

  • Johns Hopkins Hospital

    Baltimore, Maryland · Completed

  • Boston Clinical Trials

    Boston, Massachusetts · Completed

  • Beaumont Hospital Royal Oak

    Royal Oak, Michigan · Completed

  • Kansas City Veterans Affairs Medical Center

    Kansas City, Missouri · Completed

  • The Neurological Institute of New York

    New York, New York · Completed

  • South Shore Neurologic Associates - Patchogue

    Patchogue, New York · Completed

  • The Neurological Institute, PA

    Charlotte, North Carolina · Completed

  • Cleveland Clinic Main Campus

    Cleveland, Ohio · Active not recruiting

  • Austin Neuromuscular Center

    Austin, Texas · Completed

  • Advocate Health - Aurora St. Luke's Medical Center

    Milwaukee, Wisconsin · Active not recruiting

  • Hospital Italiano de Buenos Aires

    Buenos Aires, Argentina · Active not recruiting

  • Instituto Fleni

    Buenos Aires, Argentina · Recruiting

  • Hospital Gral Agudos Ignacio Pirovano

    Buenos Aires, Argentina · Completed

  • INECO Neurociencias Orono

    Rosario, Argentina · Recruiting

  • The Alfred Hospital

    Melbourne, Australia · Completed

  • Gold Coast University Hospital

    Parkwood, Australia · Completed

  • The Ottawa Hospital Ottawa NeuroMuscular Centre

    Ottawa, Canada · Recruiting

  • Peking University First Hospital

    Beijing, China · Completed

  • Xuanwu Hospital ,Capital Medical University

    Beijing, China · Active not recruiting

  • Beijing Tiantan Hospital, Capital Medical University

    Beijing, China · Active not recruiting

  • Peking University Third Hospital

    Beijing, China · Completed

  • The First Hospital of Jilin University

    Changchun, China · Active not recruiting

  • The Third Xiangya Hospital of Central Sourth University

    Changsha, China · Active not recruiting

  • Xiangya Hospital Central South University

    Changsha, China · Completed

  • Sichuan Provincial Peoples Hospital

    Chengdu, China · Completed

  • Chifeng Municipal Hospital

    Chifeng, China · Completed

  • Fujian Medical University Union Hospital

    Fuzhou, China · Active not recruiting

  • The First Affiliated Hospital Sun Yat sen University

    Guangzhou, China · Active not recruiting

  • Qilu Hospital of Shandong University

    Jinan, China · Active not recruiting

  • Qianfoshan hospital of Shandong Province

    Jinan, China · Completed

  • The First Affiliated Hospital of NanChang University

    Nanchang, China · Active not recruiting

  • Huashan Hospital Fudan University

    Shanghai, China · Active not recruiting

  • Tong Ren Hospital Shanghai Jiao Tong University school of medicine

    Shanghai, China · Completed

  • Renmin Hospital of Wuhan University

    Wuhan, China · Completed

Showing 40 of 120 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.